Clinical, ethical, and quality-of-life outcomes in unresectable hepatocellular carcinoma: the LEAP-012 trial. Sherry AD, Dudzinski SO, Ludmir EB. Lancet 2025;406:693-694.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sherry AD, Dudzinski SO, Ludmir EB. Clinical, ethical, and quality-of-life outcomes in unresectable hepatocellular carcinoma: the LEAP-012 trial. Lancet 2025;406:693-694.
PMID: 40818847